WWM
ABBV icon

Windsor Wealth Management’s AbbVie ABBV Stock Holding History

Windsor Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.31M Sell
15,534
-40
-0.3% -$5.87K 0.42% 51
2023
Q2 		$2.1M Buy
15,574
+6
+0% +$880 0.38% 52
2023
Q1 		$2.51M Sell
15,568
-126
-0.8% -$19.3K 0.49% 47
2022
Q4 		$2.61M Sell
15,694
-3
-0% -$460 0.54% 45
2022
Q3 		$2.18M Sell
15,697
-38
-0.2% -$5.45K 0.54% 38
2022
Q2 		$2.4M Sell
15,735
-642
-4% -$98.1K 0.61% 33
2022
Q1 		$2.87M Buy
16,377
+65
+0.4% +$9.44K 0.53% 41
2021
Q4 		$2.21M Sell
16,312
-1,818
-10% -$215K 0.4% 50
2021
Q3 		$1.98M Buy
18,130
+420
+2% +$48K 0.41% 48
2021
Q2 		$2M Buy
17,710
+243
+1% +$27.4K 0.43% 46
2021
Q1 		$1.89M Buy
17,467
+955
+6% +$102K 0.45% 45
2020
Q4 		$1.77M Buy
16,512
+170
+1% +$16.3K 0.45% 46
2020
Q3 		$1.37M Sell
16,342
-211
-1% -$19.9K 0.4% 55
2020
Q2 		$1.63M Buy
16,553
+253
+2% +$22.3K 0.52% 44
2020
Q1 		$1.24M Sell
16,300
-37
-0.2% -$3.15K 0.5% 47
2019
Q4 		$1.45M Buy
16,337
+12
+0.1% +$996 0.53% 45
2019
Q3 		$1.18M Sell
16,325
-220
-1% -$15.1K 0.51% 51
2019
Q2 		$1.21M Buy
16,545
+13,330
+415% +$1.05M 0.53% 49
2019
Q1 		$259K Sell
3,215
-4,394
-58% -$359K 0.15% 129
2018
Q4 		$701K Sell
7,609
-173
-2% -$15.2K 0.48% 63
2018
Q3 		$736K Sell
7,782
-1,052
-12% -$99.8K 0.48% 58
2018
Q2 		$818K Sell
8,834
-300
-3% -$29.3K 0.64% 36
2018
Q1 		$865K Buy
9,134
+200
+2% +$22K 0.73% 27
2017
Q4 		$864K Buy
+8,934
New +$842K 0.74% 29

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Windsor Wealth Management's ABBV Position: Q3 2023 in Review

Windsor Wealth Management reduced its AbbVie (ABBV) stake by 0.26% in Q3 2023, selling an estimated $5.87K and leaving 15,534 shares worth $2.31M. The position accounts for 0.42% of the portfolio, ranked #51.

Windsor Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 24 quarters since. The position peaked at $2.87M in Q1 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Windsor Wealth Management held 15,534 shares of AbbVie worth $2.31M as of Q3 2023.
  • Windsor Wealth Management sold 40 AbbVie shares in Q3 2023, an estimated $5.87K.
  • AbbVie made up 0.42% of Windsor Wealth Management's portfolio in Q3 2023, its #51 holding.
  • Windsor Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 24 quarters since.
  • Windsor Wealth Management's AbbVie position peaked at $2.87M in Q1 2022.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Windsor Wealth Management's 13F filing for Q3 2023, filed 24 Oct 2023.